Healthcare News

Daix (France), New York City (New York, United States), May 13, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on...

Daix (France), New York City (New York, Etats-Unis), le 13 mai 2026 – Inventiva (Euronext Paris et NASDAQ: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique au stade clinique...

BOSTON et LONDRES, 13 mai 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences et Deliver Biosciences ont annoncé aujourd’hui que Fortis avait nommé Deliver Biosciences premier bénéficiaire de la Fortis...

BOSTON und LONDON, May 13, 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences und Deliver Biosciences gaben heute bekannt, dass Fortis Deliver Biosciences zum ersten Preisträger der „Fortis Grant Series...

SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through...

Fangzhou presented its innovative “AI+Chronic Disease Service” solutions, addressing some of the most pressing challenges in chronic disease care.

Wegovy® pill showed 21.6% weight loss in early responders and improved mobility in OASIS-4 data at ECO2026.

SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,...

COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026. Revenue for the first three...

KØBENHAVN, Danmark, 13. maj 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab samt rapporterede på begivenheder for første kvartal 2026. Omsætningen i de første tre måneder var...